【百洋医药旗下同昕生物自主研发的鼻咽癌辅助诊断试剂盒获批上市】金十数据11月1日讯，近日，百洋医药集团旗下同昕生物自主研发的鼻咽癌诊断系列试剂盒EB病毒Rta蛋白IgG抗体检测试剂盒（化学发光免疫分析法）成功获得国家药监局批准上市。该产品为同昕生物自主研发的第三代鼻咽癌辅助诊断试剂，基于全自动磁微粒化学发光平台，结果更稳定，可满足更多元的临床诊断需求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.